Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep;148(3):335-43.
doi: 10.1016/j.clim.2012.11.001. Epub 2012 Nov 12.

Cytokine inhibition as a strategy for treating systemic lupus erythematosus

Daniel N Clark  1 , Jillian L Markham, Chad S Sloan, Brian D Poole
Affiliations
Review

Cytokine inhibition as a strategy for treating systemic lupus erythematosus

Daniel N Clark et al. Clin Immunol. 2013 Sep.

Abstract

Cytokines regulate and control the immune system. In systemic lupus erythematosus, several of these cytokines are overexpressed and contribute to the pathogenesis of the disease. Cytokine inhibition has been successfully used to treat other rheumatic and autoimmune diseases, and several cytokines are currently being investigated to determine whether inhibition would be therapeutic in lupus. The cytokines discussed in this review have all undergone clinical trials, and include TNF-α, IL-1, IL-6, IL-10, IL-15, IL-17, IL-18 and IL-23. Inhibition of the majority of these targets was safe and showed some efficacy in treating lupus. Cytokine inhibition strategies have just started to realize their potential for the treatment of this difficult disease, and show great promise for the future.

Keywords: Cytokine Inhibitors; Lupus.

PubMed Disclaimer

MeSH terms